Announcements Trials

Browse Landscape

Phase

Phase 2 2 Phase 1/2 2 Phase NA 1 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Whooping Cough 1 Pneumococcal Infections 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Measles 1 Inflammatory Bowel Diseases 1 Hepatitis B 1 HIV Infections 1 Crohn Disease 1 Colitis, Ulcerative 1

Interventions

Cyclophosphamide 18 fludarabine phosphate 14 Peripheral Blood Stem Cell Transplantation 13 Cyclosporine 12 Whole-Body Irradiation 11 Antilymphocyte Serum 10 fludarabine 9 Exercise 9 Busulfan 9 Mycophenolic Acid 8 Melphalan 8 Dexamethasone 8 Blood Specimen Collection 8 Filgrastim 7 Standard of Care 6 Radiotherapy 6 Behavior Therapy 6 Acupuncture Therapy 6 Therapeutics 5 Specimen Handling 5 Palliative Care 5 Methotrexate 5 Granulocyte Colony-Stimulating Factor 5 Etoposide 5 Educational Status 5 Surveys and Questionnaires 4 Stem Cell Transplantation 4 Psychiatric Rehabilitation 4 Practice Guidelines as Topic 4 Methylprednisolone 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Multiple Myeloma × Pneumococcal Vaccines × Clear all

NCT01852591 2017-02-02

PCV13

H. Lee Moffitt Cancer Center and Research Institute

Phase NA Completed

8 enrolled 10 charts

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡